`Filed: June 16, 2016
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________
`
`COALITION FOR AFFORDABLE DRUGS VI LLC
`
`Petitioner,
`
`v.
`
`CELGENE CORPORATION
`
`Patent Owner
`
`________________
`
`Case IPR2015-01103
`Patent 6,315,720
`________________
`
`
`
`
`
`
`
`
`
`PATENT OWNER’S REQUEST FOR ORAL ARGUMENT
`PURSUANT TO 37 C.F.R. § 42.70
`
`
`
`
`
`
`
`
`
`
`
`Patent Owner Request for Oral Argument Case IPR2015-01103
`Patent 6,315,720
`
`
`Patent Owner, Celgene Corporation (“Celgene”), hereby requests that oral
`
`argument be held before the Patent Trial and Appeal Board (the “Board”) pursuant
`
`to 37 C.F.R. § 42.70 and the Board’s October 27, 2015 Scheduling Order (Paper
`
`23). As set forth in its Order, the Board has currently scheduled the oral hearing
`
`for July 21, 2016. This request encompasses each of the issues addressed in
`
`Petitioner’s Petition (as applicable after institution) and Reply, Patent Owner’s
`
`Response, and all exhibits thereto, including declarations and depositions. The
`
`specific issues Patent Owner wishes to address are set forth below, without waiver
`
`or prejudice.
`
`1.
`
`2.
`
`ISSUES TO BE ARGUED
`
`The correct definition of a person of ordinary skill in the art for this
`
`proceeding.
`
`Claim construction – The proper construction of the term
`
`“prescription approval code.”
`
`3. Whether Petitioner’s Reply contains improper reply evidence and
`
`arguments.
`
`4. Whether Petitioner has met its burden of proving the challenged
`
`claims of U.S. Patent No. 6,315,720 (Ex. 1001) unpatentable as
`
`obvious over Mitchell (Ex. 1010) and Dishman (Ex. 1007) in view of
`
`Cunningham (Ex. 1008) and further in view of Mundt (Ex. 1017),
`
`
`
`
`
`Patent Owner Request for Oral Argument Case IPR2015-01103
`Patent 6,315,720
`
`Mann (Ex. 1018), Vanchieri (Ex. 1019), Shinn (Ex. 1020), Linnarsson
`
`(Ex. 1021), Grönroos (Ex. 1022), Soyka (Ex. 1023), Hamera (Ex.
`
`1024), Kosten (Ex. 1025), and Mennill (Ex. 1026).
`
`Patent Owner’s and Petitioner’s Motion(s) to Exclude Evidence, if
`
`any.
`
`Responses to any issues raised by Petitioner in its Request for Oral
`
`Argument or at the oral hearing.
`
`Any other issues that the Board deems necessary for issuing a final
`
`written decision.
`
`5.
`
`6.
`
`7.
`
`Patent Owner respectfully requests that the Board provide audio-visual
`
`equipment to display demonstrative exhibits, including a projector and screen.
`
`Finally, Celgene notes that the patent at-issue in this IPR is also being
`
`reviewed in IPR2015-01096 and -1102. Further, Celgene owns another patent that
`
`is currently being reviewed in IPR2015-01092. The trial for those three
`
`proceedings has also been scheduled for July 21, 2016. Celgene respectfully
`
`requests a combined hearing for all four proceedings, with 45 minutes of oral
`
`argument time per side in the combined oral hearing.
`
`2
`
`
`
`
`
`
`
`
`Patent Owner Request for Oral Argument Case IPR2015-01103
`Patent 6,315,720
`
`
`Date: June 16, 2016
`
` Respectfully submitted,
`
`By: /F. Dominic Cerrito (Reg. No. 38,100)/
` F. Dominic Cerrito (Reg. No. 38,100)
` Andrew S. Chalson (pro hac vice)
` Eric C. Stops (Reg. No. 51,163)
` Frank C. Calvosa (Reg. No. 69,064)
` QUINN EMANUEL URQUHART &
` SULLIVAN, LLP
` 51 Madison Avenue, 22nd Floor
` New York, NY 10010
` Tel: (212) 849-7000
` Fax: (212) 849-7100
` nickcerrito@quinnemanuel.com
` ericstops@quinnemanuel.com
` andrewchalson@quinnemanuel.com
` frankcalvosa@quinnemanuel.com
`
`Anthony M. Insogna (Reg. No. 35,203)
`J. Patrick Elsevier (Reg. No. 44,668)
`JONES DAY
`12265 El Camino Real
`Suite 200
`San Diego, CA 92130
`Tel: (858) 314-1200
`Fax: (858) 314-1150
`aminsogna@jonesday.com
`jpelsevier@jonesday.com
`
`Gasper J. LaRosa
`JONES DAY
`222 E 41st Street
`New York, NY 10017
`Tel: (212) 326-3939
`Fax: (212) 755-7306
`gjlarosa@jonesday.com
`
`Attorneys for Celgene Corporation
`
`
`
`3
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________
`
`COALITION FOR AFFORDABLE DRUGS VI LLC
`
`Petitioner,
`
`v.
`
`CELGENE CORPORATION
`
`Patent Owner
`
`________________
`
`Case IPR2015-01103
`Patent 6,315,720
`________________
`
`CERTIFICATE OF SERVICE
`
`
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), the undersigned hereby certifies that PATENT
`
`OWNER’S REQUEST FOR ORAL ARGUMENT PURSUANT TO 37 C.F.R.
`
`§ 42.70 was served on June 16, 2016 by filing this document through the Patent
`
`Review Processing System, as well as e-mailing a copy to
`
`sabdullah@skiermontderby.com, sspires@skiermontderby.com,
`
`pkota@skiermontderby.com, and pskiermont@skiermontderby.com.
`
`
` Respectfully submitted,
`
`By: /F. Dominic Cerrito (Reg. No. 38,100)/
` F. Dominic Cerrito (Reg. No. 38,100)
` QUINN EMANUEL URQUHART &
` SULLIVAN, LLP
` 51 Madison Avenue, 22nd Floor
` New York, NY 10010
` General Tel: (212) 849-7000
`Fax: (212) 849-7100
`nickcerrito@quinnemanuel.com
`
`Lead Counsel for
`Celgene Corporation
`
`
`
`
`Date: June 16, 2016